2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Uterine Cervical Neoplasms
2
Hepatitis B
2
Whooping Cough
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Solid Tumor
1
Pneumococcal Infections
1
Neoplasm Metastasis
1
Measles
1
HIV Infections
1
Gallstones
1
Depression
1
Condylomata Acuminata
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Anxiety Disorders
1
Interventions
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
15
Vaccines, Synthetic
10
Papillomavirus Vaccines
7
Vaccines
5
Imiquimod
4
Trichloroacetic Acid
3
Gels
3
human papillomavirus vaccine, L1 type 16, 18
2
green tea extract polyphenone E
2
Podophyllin
2
Human Papillomavirus Recombinant Vaccine nonavalent
2
Ethanol
2
Duration of Therapy
2
Cryotherapy
2
Cantharidin
2
ranpirnase
1
polyphenon E
1
nanocurcumin
1
hecolin
1
berdazimer sodium
1
Zinc
1
Viusid
1
Vaccination
1
VP-102
1
Tuberculin
1
Therapies, Investigational
1
Tea
1
Surgical Procedures, Operative
1
PRA1 protein, Candida albicans
1
Omiganan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Condylomata Acuminata
×
Hepatitis B Vaccines
×
Clear all
NCT02750202
2026-01-23
TheraVACCS
University of Pretoria
Phase 3
Completed
52 enrolled
34 charts